- Clinical Trials
- Corporate Societal Engagement
- Gender Pay Gap report
- Industrial Batteries
- Modern Slavery Act Statements
How Bayer Works Together with Healthcare Professionals
Industry and healthcare professionals collaborate in a range of activities in preclinical research, clinical development as well as clinical practice and patient outcome.
As the primary point of contact with patients, healthcare professionals offer invaluable and expert knowledge on patient outcomes and the management of diseases. This plays a crucial role in optimising our efforts to improve patient care, treatment options and patient outcomes.
Collaboration example 1: Clinical Trials
Patients Need the Right Medicines
Patients can only truly benefit from the huge amount of invaluable medical knowledge that exists worldwide when our internal experts work closely together with external researchers and healthcare professionals. We strongly believe that the joint use of this expertise will help us to gain a better understanding of major diseases and to develop better medicines faster. The treating physician and other healthcare professionals conduct clinical trials at study centres in accordance with the clinical study protocol as approved by health authorities, institutional review boards, and ethics committees. Thus, they are the major link to the participating patients and are responsible for collecting data. Expertise and time offered by healthcare professionals and healthcare organisations in the course of a clinical trial need to be compensated.
Collaboration Example 2: Supporting Physician’s Education
Patients Need the Best Informed Doctors
Bayer develops innovative medicines. Novel treatments have to be introduced and explained to healthcare professionals to ensure their responsible use. Therefore, we support the education of healthcare professionals through attendance at medical congresses and trainings. This contributes to ensuring doctors have access to the latest medical research and are thus able to prescribe the best treatment option for their patients. Only then can we fulfil our commitment to support the correct use of our new treatments. Scientific events are just one of many resources for physician’s education.
Collaboration Example 3: Helping the NHS
Patients need Access to Medicines
Once a new medicine has been launched and made available to patients there is often considerable work to be done by the NHS locally to ensure there are systems and services in place to enable patients to access these medicines. Bayer works with GP practices, CCGs, Hospital Trusts and Academic Health Science Networks (AHSN) in England and their equivalents across the UK to support these activities with the provision of medical services and the secondment of personnel with the required experience into these organisations.
This support is fully documented in Joint Working Agreements or Medical Education Goods and Services, all of which have to go through a thorough medical and legal review before they can be implemented by Bayer but also by the organisations that are being supported.
Bayer also supports patient organisations and charities in their work to ensure that patients have access to the highest quality information and advice, informing them about their condition and empowering them to make informed decisions with their health care professionals..